Filing Details
- Accession Number:
- 0001140361-18-003241
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-25 17:09:04
- Reporting Period:
- 2018-01-22
- Accepted Time:
- 2018-01-25 17:09:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1581720 | Loxo Oncology Inc. | LOXO | Pharmaceutical Preparations (2834) | 462996673 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1612217 | Z. Avi Naider | C/O Loxo Oncology, Inc. 281 Tresser Blvd, 9Th Floor Stamford CT 06901 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-01-22 | 3,000 | $0.00 | 141,118 | No | 5 | G | Direct | |
Common Stock | Disposition | 2018-01-22 | 15,000 | $100.00 | 126,118 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 4 | S | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.